Mild elevation of body temperature reduces tumor interstitial fluid pressure and hypoxia and enhances efficacy of radiotherapy in murine tumor models.

Human and rodent solid tumors often exhibit elevated interstitial fluid pressure (IFP). This condition is recognized as a prognostic indicator for reduced responses to therapy and decreased disease-free survival rate. In the present study, we tested whether induction of a thermoregulatory-mediated increase in tissue blood flow, induced by exposure of mice to mild environmental heat stress, could influence IFP and other vascular parameters within tumors. Using several murine tumor models, we found that heating results in a sustained reduction in tumor IFP correlating with increased tumor vascular perfusion (measured by fluorescent imaging of perfused vessels, laser Doppler flowmetry, and MRI) as well as a sustained reduction in tumor hypoxia. Furthermore, when radiation therapy was administered 24 hours postheating, we observed a significant improvement in efficacy that may be a result of the sustained reduction in tumor hypoxia. These data suggest, for the first time, that environmental manipulation of normal vasomotor function is capable of achieving therapeutically beneficial changes in IFP and microvascular function in the tumor microenvironment.

[1]  Peter Wust,et al.  Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. , 2010, The Lancet. Oncology.

[2]  E. Rofstad,et al.  Associations between Radiocurability and Interstitial Fluid Pressure in Human Tumor Xenografts without Hypoxic Tissue , 2010, Clinical Cancer Research.

[3]  P. Vaupel,et al.  Pathophysiological and vascular characteristics of tumours and their importance for hyperthermia: Heterogeneity is the key issue , 2010, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[4]  Robert J Griffin,et al.  Mild temperature hyperthermia and radiation therapy: Role of tumour vascular thermotolerance and relevant physiological factors , 2010, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[5]  S. Ferretti,et al.  Tumor interstitial fluid pressure as an early-response marker for anticancer therapeutics. , 2009, Neoplasia.

[6]  Arjun G. Yodh,et al.  Epidermal Growth Factor Receptor Inhibition Modulates the Microenvironment by Vascular Normalization to Improve Chemotherapy and Radiotherapy Efficacy , 2009, PloS one.

[7]  V. Yang,et al.  Interstitial fluid pressure, vascularity and metastasis in ectopic, orthotopic and spontaneous tumours , 2008, BMC Cancer.

[8]  J. R. Roti Roti Cellular responses to hyperthermia (40–46°C): Cell killing and molecular events , 2008, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[9]  J. Bull,et al.  Fever-range whole-body thermal therapy combined with cisplatin, gemcitabine, and daily interferon-α: A description of a phase I-II protocol , 2008, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[10]  Dai Fukumura,et al.  Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. , 2007, Microvascular research.

[11]  Mark W. Dewhirst,et al.  Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment , 2007, Cancer and Metastasis Reviews.

[12]  B. Hylander,et al.  Fever-range whole body hyperthermia increases the number of perfused tumor blood vessels and therapeutic efficacy of liposomally encapsulated doxorubicin , 2007, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[13]  I. Tannock,et al.  Drug penetration in solid tumours , 2006, Nature Reviews Cancer.

[14]  M. Dewhirst,et al.  Thermal medicine, heat shock proteins and cancer , 2005, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[15]  A. Hargens,et al.  A simple method for measuring interstitial fluid pressure in cancer tissues. , 2005, Microvascular research.

[16]  Y. Boucher,et al.  Paclitaxel decreases the interstitial fluid pressure and improves oxygenation in breast cancers in patients treated with neoadjuvant chemotherapy: clinical implications. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Y. Rustum,et al.  Lack of Microvessels in Well-Differentiated Regions of Human Head and Neck Squamous Cell Carcinoma A253 Associated with Functional Magnetic Resonance Imaging Detectable Hypoxia, Limited Drug Delivery, and Resistance to Irinotecan Therapy , 2004, Clinical Cancer Research.

[18]  Kristian Pietras,et al.  High interstitial fluid pressure — an obstacle in cancer therapy , 2004, Nature Reviews Cancer.

[19]  Peter Vaupel,et al.  Tumor microenvironmental physiology and its implications for radiation oncology. , 2004, Seminars in radiation oncology.

[20]  C. Song,et al.  Physiological mechanisms underlying heat-induced radiosensitization , 2004, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[21]  Rakesh K. Jain,et al.  Pathology: Cancer cells compress intratumour vessels , 2004, Nature.

[22]  H. Dvorak,et al.  Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma. , 2003, The American journal of pathology.

[23]  Nisha Charkoudian,et al.  Skin blood flow in adult human thermoregulation: how it works, when it does not, and why. , 2003, Mayo Clinic proceedings.

[24]  A. Fyles,et al.  Interstitial Fluid Pressure in Cervical Cancer: Guide to Targeted Therapy , 2001, American journal of clinical oncology.

[25]  Robert J. Griffin,et al.  Improvement of Tumor Oxygenation by Mild Hyperthermia , 2001, Radiation research.

[26]  C. Reilly,et al.  Intravenous anaesthesia and the rat microcirculation: the dorsal microcirculatory chamber. , 2000, British journal of anaesthesia.

[27]  M Ancukiewicz,et al.  Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. , 2000, Cancer research.

[28]  R. Jain,et al.  Oncotic pressure in solid tumors is elevated. , 2000, Cancer research.

[29]  R K Jain,et al.  Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications. , 1999, Cancer research.

[30]  M. Caligiuri,et al.  Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever‐like) whole body hyperthermia , 1998, Journal of cellular physiology.

[31]  J. Bull,et al.  Apoptosis in tumors and normal tissues induced by whole body hyperthermia in rats. , 1995, Cancer research.

[32]  R K Jain,et al.  Pharmacologic modification of tumor blood flow and interstitial fluid pressure in a human tumor xenograft: network analysis and mechanistic interpretation. , 1995, Microvascular research.

[33]  J. Bull,et al.  Therapeutic efficacy of long duration-low temperature whole body hyperthermia when combined with tumor necrosis factor and carboplatin in rats. , 1994, Cancer Research.

[34]  C. Gordon Temperature Regulation in Laboratory Rodents , 1993 .

[35]  G. Rosner,et al.  Effects of bradykinin on the hemodynamics of tumor and granulating normal tissue microvasculature. , 1992, Radiation research.

[36]  R. Jain,et al.  Interstitial fluid pressure in solid tumors following hyperthermia: possible correlation with therapeutic response. , 1992, Cancer research.

[37]  R K Jain,et al.  Interstitial hypertension in carcinoma of uterine cervix in patients: possible correlation with tumor oxygenation and radiation response. , 1991, Cancer research.

[38]  P. Olive,et al.  Use of a carbocyanine dye as a marker of functional vasculature in murine tumours. , 1989, British Journal of Cancer.

[39]  C. J. Gordon,et al.  Behavioral and autonomic thermoregulation in mice exposed to microwave radiation. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

[40]  C. Gordon Influence of heating rate on control of heat loss from the tail in mice. , 1983, The American journal of physiology.

[41]  Ardenne Mv [Synergic therapeutic effect of selective local hyperthermia and selective optimized hyperacidity against tumors. Theoretical and experimental bases]. , 1977, Therapie der Gegenwart.

[42]  A. Guyton,et al.  Textbook of Medical Physiology , 1961 .

[43]  Y. Sekido,et al.  Hepatocyte Growth Factor Reduces Susceptibility to an Irreversible Epidermal Growth Factor Receptor Inhibitor in EGFR-T790M Mutant Lung Cancer , 2010 .

[44]  Rakesh K. Jain,et al.  Transport of molecules across tumor vasculature , 2004, Cancer and Metastasis Reviews.

[45]  Meiyappan Solaiyappan,et al.  Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-470. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[46]  M. Dewhirst,et al.  A local hyperthermia treatment which enhances antibody uptake in a glioma xenograft model does not affect tumour interstitial fluid pressure. , 1997, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[47]  C. Gordon Temperature regulation in laboratory rodents: Thermoregulatory effector responses , 1993 .

[48]  U Schmiedl,et al.  Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: biodistribution and imaging studies. , 1987, Radiology.

[49]  H. Bernheim Temperature Regulation and Fever , 1985 .